University of Colorado Cancer Center


 

ASCO® 2023 Insights: "Effect of CBM588 in Combination With Cabozantinib + Nivolumab for Patients With mRCC - A Randomized Clinical Trial"

105 views
June 14, 2023
Comments 0
Login to view comments. Click here to Login